This hit $2.39 Wednesday from my low alert on this News... CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer I guess shorts hit it maybe counting on a financing like we see so often after news. But now, the insiders are buying open market stock which means there isnt any financing right now imo. https://finance.yahoo.com/news/cel-sci-receives-fda-ahead-130000511.html